Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Granneman

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetics of temafloxacin after multiple oral administrationG R Granneman
Clinical Pharmacokinetics|January 1, 1992
The effect of food on the bioavailability of temafloxacin. A review of 3 studiesG R Granneman, D Mukherjee
The American Journal of Medicine|December 30, 1991
The influence of age on the pharmacokinetics of temafloxacinG R Granneman, D R Guay
Journal of Pharmaceutical Sciences|October 1, 1982
Precise high-performance liquid chromatographic procedure for the determination of cefsulodin, a new antipseudomonal cephalosporin antibiotic, in plasmaG R Granneman, L T Sennello
Journal of Chromatography|July 17, 1991
High-performance liquid chromatographic procedures for the determination of temafloxacin in biological matricesG R Granneman, L L Varga
Journal of Chromatography|April 16, 1982
A very precise high-performance liquid chromatographic procedure for the determination of cefmenoxime, a new cephalosporin antibiotic, in plasmaG R Granneman, L T Sennello
Journal of Chromatography|January 23, 1987
High-performance liquid chromatographic procedures for the determination of difloxacin and its metabolites in biological matricesG R Granneman, L T Sennello
Journal of Pharmaceutical Sciences|April 3, 1999
Modeling of sertindole pharmacokinetic disposition in healthy volunteers in short term dose-escalation studiesS L Wong, G R Granneman
Clinical Pharmacokinetics|March 1, 1997
Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactionsR J Bertz, G R Granneman
Clinical Pharmacokinetics|November 13, 1998
Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agentsA Hsu, G R Granneman, R J Bertz
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetics of temafloxacin after multiple oral administrationG R Granneman
Clinical Pharmacokinetics|January 1, 1992
The effect of food on the bioavailability of temafloxacin. A review of 3 studiesG R Granneman, D Mukherjee
The American Journal of Medicine|December 30, 1991
The influence of age on the pharmacokinetics of temafloxacinG R Granneman, D R Guay
Journal of Pharmaceutical Sciences|October 1, 1982
Precise high-performance liquid chromatographic procedure for the determination of cefsulodin, a new antipseudomonal cephalosporin antibiotic, in plasmaG R Granneman, L T Sennello
Journal of Chromatography|July 17, 1991
High-performance liquid chromatographic procedures for the determination of temafloxacin in biological matricesG R Granneman, L L Varga
Journal of Chromatography|April 16, 1982
A very precise high-performance liquid chromatographic procedure for the determination of cefmenoxime, a new cephalosporin antibiotic, in plasmaG R Granneman, L T Sennello
Journal of Chromatography|January 23, 1987
High-performance liquid chromatographic procedures for the determination of difloxacin and its metabolites in biological matricesG R Granneman, L T Sennello
Journal of Pharmaceutical Sciences|April 3, 1999
Modeling of sertindole pharmacokinetic disposition in healthy volunteers in short term dose-escalation studiesS L Wong, G R Granneman
Clinical Pharmacokinetics|March 1, 1997
Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactionsR J Bertz, G R Granneman
Clinical Pharmacokinetics|November 13, 1998
Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agentsA Hsu, G R Granneman, R J Bertz
Pageof 9